Novo Nordisk inks OpenAI deal

Novo Nordisk announced a strategic partnership with OpenAI to apply AI across drug discovery, manufacturing and delivery operations. The announcement sits alongside the company’s broader AI portfolio, including a reported $1bn partnership with Nvidia and a $2.75bn deal with Insilico Medicine. (cnbc.com / pharmaceutical-technology.com)